feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    UID:
    almafu_BV036069148
    Format: 1 Online-Ressource (VIII, 167 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-8055-8506-4
    Series Statement: Contributions to nephrology Vol. 159
    Content: Initially conceived as a strategy to remedy inherited genetic disorders, gene therapy has been successfully applied in the last decade to ameliorate the renal function compromised by progressive renal diseases and to prevent kidney allograft rejection in experimental animals.In the present book, world-renowned experts are presenting new insights into viral and non-viral systems used to effect gene delivery, one chapter being dedicated to the new field of RNA interference (RNAi). This latter method may be successfully used in renal ischemia-reperfusion injury, trauma and transplantation. In the near future, gene therapy might also prove to be a new strategy to target molecules involved in tissue damage and inflammation processes that underlie ARF. So far, gene transfer has been successfully applied in experimental glomerulonephritis and interstitial fibrosis, and studies in larger animals are keenly awaited. Also covered are issues related to transplantation, which is the therapy of choice in many end-stage organ failures. Transfer of genes whose protein products have immunomodulatory properties have proven beneficial in treating acute and chronic graft rejection, one of the problems not satisfactorily solved by current anti-rejection drugs. Gene therapy thus may become a reality in clinical transplantation once its efficacy in larger animals has been demonstrated. Last but not least, a possible benefit of targeted gene therapy in renal cancer or HIV-associated nephropathy is explored.Covering a wide spectrum of topics, this publication provides a valuable overview of current developments and issues
    Note: a survey of potential fields of application. - Includes bibliographical references and indexes
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8505-7
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierenkrankheit ; Gentherapie ; Niere ; Gentransfer ; Nierentransplantation ; Transplantatabstoßung ; Gentherapie ; Aufsatzsammlung
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    UID:
    almafu_BV036069219
    Format: 1 Online-Ressource (VIII, 155 Seiten).
    ISBN: 978-3-318-01168-5
    Series Statement: Contributions to nephrology Vol. 146
    Content: Transplantation is today firmly established as the therapy of choice for end-stage organ failure. However, despite recent developments, this therapy is still not without challenges and risks: The necessity to take immunosuppressive drugs for the rest of one’s life to prevent allograft rejection trades the morbidity and mortality of organ failure for the risks of infection and cancer as well as for an increased mortality from cardiovascular disease. Thus, there is an urgent need for optimizing the outcome of transplantation by achieving long-term, drug-free graft acceptance with normal organ function.Recently, numerous insights into the dynamic inter-relationship of host immune responses elicited by donor antigen presentation have substantially broadened our understanding of the cascade of events resulting in the acquisition of tolerance. With the pharmacopoeia of the transplant biologist continually expanding, the potential treatment combinations have become baffling and their impact on strategies to induce tolerance even more complex.This book presents novel insights into the pathways of acute rejection and their monitoring through molecular tests, new immunosuppressive agents currently under development as well as the most recent and promising approaches to induce tolerance that have emerged from experimental animal studies
    Note: a guide to new developments
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7856-1
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Nierentransplantation ; Transplantatabstoßung ; Prävention ; Aufsatzsammlung
    Author information: Ronco, Claudio 1951-
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    UID:
    edoccha_BV036069148
    Format: 1 Online-Ressource (VIII, 167 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-8055-8506-4
    Series Statement: Contributions to nephrology Vol. 159
    Content: Initially conceived as a strategy to remedy inherited genetic disorders, gene therapy has been successfully applied in the last decade to ameliorate the renal function compromised by progressive renal diseases and to prevent kidney allograft rejection in experimental animals.In the present book, world-renowned experts are presenting new insights into viral and non-viral systems used to effect gene delivery, one chapter being dedicated to the new field of RNA interference (RNAi). This latter method may be successfully used in renal ischemia-reperfusion injury, trauma and transplantation. In the near future, gene therapy might also prove to be a new strategy to target molecules involved in tissue damage and inflammation processes that underlie ARF. So far, gene transfer has been successfully applied in experimental glomerulonephritis and interstitial fibrosis, and studies in larger animals are keenly awaited. Also covered are issues related to transplantation, which is the therapy of choice in many end-stage organ failures. Transfer of genes whose protein products have immunomodulatory properties have proven beneficial in treating acute and chronic graft rejection, one of the problems not satisfactorily solved by current anti-rejection drugs. Gene therapy thus may become a reality in clinical transplantation once its efficacy in larger animals has been demonstrated. Last but not least, a possible benefit of targeted gene therapy in renal cancer or HIV-associated nephropathy is explored.Covering a wide spectrum of topics, this publication provides a valuable overview of current developments and issues
    Note: a survey of potential fields of application. - Includes bibliographical references and indexes
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8505-7
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierenkrankheit ; Gentherapie ; Niere ; Gentransfer ; Nierentransplantation ; Transplantatabstoßung ; Gentherapie ; Aufsatzsammlung
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    UID:
    almahu_BV036069219
    Format: 1 Online-Ressource (VIII, 155 Seiten).
    ISBN: 978-3-318-01168-5
    Series Statement: Contributions to nephrology Vol. 146
    Content: Transplantation is today firmly established as the therapy of choice for end-stage organ failure. However, despite recent developments, this therapy is still not without challenges and risks: The necessity to take immunosuppressive drugs for the rest of one’s life to prevent allograft rejection trades the morbidity and mortality of organ failure for the risks of infection and cancer as well as for an increased mortality from cardiovascular disease. Thus, there is an urgent need for optimizing the outcome of transplantation by achieving long-term, drug-free graft acceptance with normal organ function.Recently, numerous insights into the dynamic inter-relationship of host immune responses elicited by donor antigen presentation have substantially broadened our understanding of the cascade of events resulting in the acquisition of tolerance. With the pharmacopoeia of the transplant biologist continually expanding, the potential treatment combinations have become baffling and their impact on strategies to induce tolerance even more complex.This book presents novel insights into the pathways of acute rejection and their monitoring through molecular tests, new immunosuppressive agents currently under development as well as the most recent and promising approaches to induce tolerance that have emerged from experimental animal studies
    Note: a guide to new developments
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7856-1
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Nierentransplantation ; Transplantatabstoßung ; Prävention ; Aufsatzsammlung
    Author information: Ronco, Claudio, 1951-
    Author information: Remuzzi, Giuseppe, 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    UID:
    almahu_BV036069185
    Format: 1 Online-Ressource (IX, 145 Seiten) : , Illustrationen.
    ISBN: 978-3-8055-8959-8
    Series Statement: Contributions to nephrology Vol. 162
    Content: As recent advances in immunosuppression and apheresis techniques have opened new avenues for the management of humoral immunity, interest in ABO-incompatible kidney transplantation has been renewed. Moreover, new screening techniques – such as the single antigen bead assay – allow for the detection and definition of very low levels of alloantibody, which has had a positive impact on the treatment possibilities in highly sensitized adult patients with end-stage renal disease. But despite these advances, a theoretical rationale is still missing for both the decision to transplant a sensitized patient and the classification of the transplant as low, medium or high risk. There is also no uniform approach with regard to pre-transplant desensitization protocols, and it is unclear whether particular post-transplant immunosuppression will be required and what would be the best combination treatment. Last but not least, the frequency and actual clinical impact of alloantibodies developed after transplantation on short- and long-term graft survival need to be ascertained.Aimed especially at the clinician, this publication presents recent insights in the characterization and pathogenetic role of humoral immunity in chronic allograft injury and investigates the perspectives for novel immunosuppressive therapies to control antibody production after transplantation
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8945-1
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierentransplantation ; Immunologie ; Aufsatzsammlung
    Author information: Ronco, Claudio, 1951-
    Author information: Remuzzi, Giuseppe, 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    UID:
    edoccha_BV036069185
    Format: 1 Online-Ressource (IX, 145 Seiten) : , Illustrationen.
    ISBN: 978-3-8055-8959-8
    Series Statement: Contributions to nephrology Vol. 162
    Content: As recent advances in immunosuppression and apheresis techniques have opened new avenues for the management of humoral immunity, interest in ABO-incompatible kidney transplantation has been renewed. Moreover, new screening techniques – such as the single antigen bead assay – allow for the detection and definition of very low levels of alloantibody, which has had a positive impact on the treatment possibilities in highly sensitized adult patients with end-stage renal disease. But despite these advances, a theoretical rationale is still missing for both the decision to transplant a sensitized patient and the classification of the transplant as low, medium or high risk. There is also no uniform approach with regard to pre-transplant desensitization protocols, and it is unclear whether particular post-transplant immunosuppression will be required and what would be the best combination treatment. Last but not least, the frequency and actual clinical impact of alloantibodies developed after transplantation on short- and long-term graft survival need to be ascertained.Aimed especially at the clinician, this publication presents recent insights in the characterization and pathogenetic role of humoral immunity in chronic allograft injury and investigates the perspectives for novel immunosuppressive therapies to control antibody production after transplantation
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8945-1
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierentransplantation ; Immunologie ; Aufsatzsammlung
    Author information: Ronco, Claudio 1951-
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 7
    UID:
    almahu_BV036069148
    Format: 1 Online-Ressource (VIII, 167 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-8055-8506-4
    Series Statement: Contributions to nephrology Vol. 159
    Content: Initially conceived as a strategy to remedy inherited genetic disorders, gene therapy has been successfully applied in the last decade to ameliorate the renal function compromised by progressive renal diseases and to prevent kidney allograft rejection in experimental animals.In the present book, world-renowned experts are presenting new insights into viral and non-viral systems used to effect gene delivery, one chapter being dedicated to the new field of RNA interference (RNAi). This latter method may be successfully used in renal ischemia-reperfusion injury, trauma and transplantation. In the near future, gene therapy might also prove to be a new strategy to target molecules involved in tissue damage and inflammation processes that underlie ARF. So far, gene transfer has been successfully applied in experimental glomerulonephritis and interstitial fibrosis, and studies in larger animals are keenly awaited. Also covered are issues related to transplantation, which is the therapy of choice in many end-stage organ failures. Transfer of genes whose protein products have immunomodulatory properties have proven beneficial in treating acute and chronic graft rejection, one of the problems not satisfactorily solved by current anti-rejection drugs. Gene therapy thus may become a reality in clinical transplantation once its efficacy in larger animals has been demonstrated. Last but not least, a possible benefit of targeted gene therapy in renal cancer or HIV-associated nephropathy is explored.Covering a wide spectrum of topics, this publication provides a valuable overview of current developments and issues
    Note: a survey of potential fields of application. - Includes bibliographical references and indexes
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8505-7
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierenkrankheit ; Gentherapie ; Niere ; Gentransfer ; Nierentransplantation ; Transplantatabstoßung ; Gentherapie ; Aufsatzsammlung
    Author information: Remuzzi, Giuseppe, 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 8
    UID:
    edoccha_BV036069219
    Format: 1 Online-Ressource (VIII, 155 Seiten).
    ISBN: 978-3-318-01168-5
    Series Statement: Contributions to nephrology Vol. 146
    Content: Transplantation is today firmly established as the therapy of choice for end-stage organ failure. However, despite recent developments, this therapy is still not without challenges and risks: The necessity to take immunosuppressive drugs for the rest of one’s life to prevent allograft rejection trades the morbidity and mortality of organ failure for the risks of infection and cancer as well as for an increased mortality from cardiovascular disease. Thus, there is an urgent need for optimizing the outcome of transplantation by achieving long-term, drug-free graft acceptance with normal organ function.Recently, numerous insights into the dynamic inter-relationship of host immune responses elicited by donor antigen presentation have substantially broadened our understanding of the cascade of events resulting in the acquisition of tolerance. With the pharmacopoeia of the transplant biologist continually expanding, the potential treatment combinations have become baffling and their impact on strategies to induce tolerance even more complex.This book presents novel insights into the pathways of acute rejection and their monitoring through molecular tests, new immunosuppressive agents currently under development as well as the most recent and promising approaches to induce tolerance that have emerged from experimental animal studies
    Note: a guide to new developments
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-7856-1
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Nierentransplantation ; Transplantatabstoßung ; Prävention ; Aufsatzsammlung
    Author information: Ronco, Claudio 1951-
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 9
    UID:
    almafu_BV036069185
    Format: 1 Online-Ressource (IX, 145 Seiten) : , Illustrationen.
    ISBN: 978-3-8055-8959-8
    Series Statement: Contributions to nephrology Vol. 162
    Content: As recent advances in immunosuppression and apheresis techniques have opened new avenues for the management of humoral immunity, interest in ABO-incompatible kidney transplantation has been renewed. Moreover, new screening techniques – such as the single antigen bead assay – allow for the detection and definition of very low levels of alloantibody, which has had a positive impact on the treatment possibilities in highly sensitized adult patients with end-stage renal disease. But despite these advances, a theoretical rationale is still missing for both the decision to transplant a sensitized patient and the classification of the transplant as low, medium or high risk. There is also no uniform approach with regard to pre-transplant desensitization protocols, and it is unclear whether particular post-transplant immunosuppression will be required and what would be the best combination treatment. Last but not least, the frequency and actual clinical impact of alloantibodies developed after transplantation on short- and long-term graft survival need to be ascertained.Aimed especially at the clinician, this publication presents recent insights in the characterization and pathogenetic role of humoral immunity in chronic allograft injury and investigates the perspectives for novel immunosuppressive therapies to control antibody production after transplantation
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8945-1
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierentransplantation ; Immunologie ; Aufsatzsammlung
    Author information: Ronco, Claudio 1951-
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 10
    UID:
    b3kat_BV036069185
    Format: 1 Online-Ressource (IX, 145 Seiten) , Illustrationen
    ISBN: 9783805589598
    Series Statement: Contributions to nephrology Vol. 162
    Content: As recent advances in immunosuppression and apheresis techniques have opened new avenues for the management of humoral immunity, interest in ABO-incompatible kidney transplantation has been renewed. Moreover, new screening techniques – such as the single antigen bead assay – allow for the detection and definition of very low levels of alloantibody, which has had a positive impact on the treatment possibilities in highly sensitized adult patients with end-stage renal disease. But despite these advances, a theoretical rationale is still missing for both the decision to transplant a sensitized patient and the classification of the transplant as low, medium or high risk. There is also no uniform approach with regard to pre-transplant desensitization protocols, and it is unclear whether particular post-transplant immunosuppression will be required and what would be the best combination treatment. Last but not least, the frequency and actual clinical impact of alloantibodies developed after transplantation on short- and long-term graft survival need to be ascertained.Aimed especially at the clinician, this publication presents recent insights in the characterization and pathogenetic role of humoral immunity in chronic allograft injury and investigates the perspectives for novel immunosuppressive therapies to control antibody production after transplantation
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-8945-1
    Language: English
    Subjects: Medicine
    RVK:
    RVK:
    Keywords: Nierentransplantation ; Immunologie ; Aufsatzsammlung
    Author information: Ronco, Claudio 1951-
    Author information: Remuzzi, Giuseppe 1949-
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages